APO Research
Talk to an analyst

APO RESEARCH · REPORT

OPO-containing Infant Formulas

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global OPO-containing Infant Formulas Industry Growth and Trends Forecast to 2032

13 August 2026106 pages

Choose your research edition.

Industry ResearchOPO-containing Infant Formulas Industry Research Report 2026125 pages · $2,950 USDIndustry Growth & TrendsGlobal OPO-containing Infant Formulas Industry Growth and Trends Forecast to 2032106 pages · $3,450 USDMarket StructureGlobal OPO-containing Infant Formulas Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal OPO-containing Infant Formulas Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal OPO-containing Infant Formulas Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global OPO-containing Infant Formulas market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for OPO-containing Infant Formulas is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for OPO-containing Infant Formulas is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for OPO-containing Infant Formulas is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of OPO-containing Infant Formulas include BiosTime, Nutriben, Ausnutria, HERDS, Milupa, Shanxi Yatai, Beingmate, Abbott and Brightdairy, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global OPO-containing Infant Formulas market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The OPO-containing Infant Formulas market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global OPO-containing Infant Formulas market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to OPO-containing Infant Formulas.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global OPO-containing Infant Formulas market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

OPO-containing Infant Formulas Market by Company

BiosTime

Nutriben

Ausnutria

HERDS

Milupa

Shanxi Yatai

Beingmate

Abbott

Brightdairy

Feihe

Wyeth Nutrition

Deloraine

Yili

Kabrita

OPO-containing Infant Formulas Segment by Type

Cow Milk Formula

Goat Milk Formula

OPO-containing Infant Formulas Segment by Application

0 - 6 Month

6 - 12 Month

12 - 36 Month

OPO-containing Infant Formulas Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global OPO-containing Infant Formulas market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of OPO-containing Infant Formulas and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of OPO-containing Infant Formulas.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of OPO-containing Infant Formulas manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of OPO-containing Infant Formulas in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Cow Milk Formula Table 2. Major Company of Goat Milk Formula Table 3. Global OPO-containing Infant Formulas Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global OPO-containing Infant Formulas Sales by Type (2021-2026) & (k units) Table 5. Global OPO-containing Infant Formulas Sales Market Share in Volume by Type (2021-2026) Table 6. Global OPO-containing Infant Formulas Sales by Type (2021-2026) & (US$ Million) Table 7. Global OPO-containing Infant Formulas Sales Market Share in Value by Type (2021-2026) Table 8. Global OPO-containing Infant Formulas Price by Type (2021-2026) & (USD/unit) Table 9. Global OPO-containing Infant Formulas Sales by Type (2027-2032) & (k units) Table 10. Global OPO-containing Infant Formulas Sales Market Share in Volume by Type (2027-2032) Table 11. Global OPO-containing Infant Formulas Sales by Type (2027-2032) & (US$ Million) Table 12. Global OPO-containing Infant Formulas Sales Market Share in Value by Type (2027-2032) Table 13. Global OPO-containing Infant Formulas Price by Type (2027-2032) & (USD/unit) Table 14. North America OPO-containing Infant Formulas Sales by Type (2021-2026) & (k units) Table 15. North America OPO-containing Infant Formulas Sales by Type (2021-2026) & (US$ Million) Table 16. Europe OPO-containing Infant Formulas Sales by Type (2021-2026) & (k units) Table 17. Europe OPO-containing Infant Formulas Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific OPO-containing Infant Formulas Sales by Type (2021-2026) & (k units) Table 19. Asia-Pacific OPO-containing Infant Formulas Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America OPO-containing Infant Formulas Sales by Type (2021-2026) & (k units) Table 21. Latin America OPO-containing Infant Formulas Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa OPO-containing Infant Formulas Sales by Type (2021-2026) & (k units) Table 23. Middle East and Africa OPO-containing Infant Formulas Sales by Type (2021-2026) & (US$ Million) Table 24. OPO-containing Infant Formulas Industry Trends Table 25. OPO-containing Infant Formulas Industry Drivers Table 26. OPO-containing Infant Formulas Industry Opportunities and Challenges Table 27. OPO-containing Infant Formulas Industry Restraints Table 28. Global OPO-containing Infant Formulas Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global OPO-containing Infant Formulas Revenue Market Share by Company (2021-2026) Table 30. Global OPO-containing Infant Formulas Sales by Company (2021-2026) & (k units) Table 31. Global OPO-containing Infant Formulas Sales Share by Company (2021-2026) Table 32. Global OPO-containing Infant Formulas Market Price by Company (2021-2026) & (USD/unit) Table 33. Global OPO-containing Infant Formulas Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global OPO-containing Infant Formulas Major Company Production Sites and Headquarters Table 35. Global OPO-containing Infant Formulas Company, Product Type & Application Table 36. Global OPO-containing Infant Formulas Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global OPO-containing Infant Formulas by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global OPO-containing Infant Formulas Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global OPO-containing Infant Formulas Sales by Region (2021-2026) & (k units) Table 41. Global OPO-containing Infant Formulas Sales Market Share in Volume by Region (2021-2026) Table 42. Global OPO-containing Infant Formulas Sales by Region (2021-2026) & (US$ Million) Table 43. Global OPO-containing Infant Formulas Sales Market Share in Value by Region (2021-2026) Table 44. Global OPO-containing Infant Formulas Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 45. Global OPO-containing Infant Formulas Sales by Region (2027-2032) & (k units) Table 46. Global OPO-containing Infant Formulas Sales Market Share in Volume by Region (2027-2032) Table 47. Global OPO-containing Infant Formulas Sales by Region (2027-2032) & (US$ Million) Table 48. Global OPO-containing Infant Formulas Sales Market Share in Value by Region (2027-2032) Table 49. Global OPO-containing Infant Formulas Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2027-2032) Table 50. Global OPO-containing Infant Formulas Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global OPO-containing Infant Formulas Sales by Application (2021-2026) & (k units) Table 52. Global OPO-containing Infant Formulas Sales Market Share in Volume by Application (2021-2026) Table 53. Global OPO-containing Infant Formulas Sales by Application (2021-2026) & (US$ Million) Table 54. Global OPO-containing Infant Formulas Sales Market Share in Value by Application (2021-2026) Table 55. Global OPO-containing Infant Formulas Price by Application (2021-2026) & (USD/unit) Table 56. Global OPO-containing Infant Formulas Sales by Application (2027-2032) & (k units) Table 57. Global OPO-containing Infant Formulas Sales Market Share in Volume by Application (2027-2032) Table 58. Global OPO-containing Infant Formulas Sales by Application (2027-2032) & (US$ Million) Table 59. Global OPO-containing Infant Formulas Sales Market Share in Value by Application (2027-2032) Table 60. Global OPO-containing Infant Formulas Price by Application (2027-2032) & (USD/unit) Table 61. North America OPO-containing Infant Formulas Sales by Application (2021-2026) & (k units) Table 62. North America OPO-containing Infant Formulas Sales by Application (2021-2026) & (US$ Million) Table 63. Europe OPO-containing Infant Formulas Sales by Application (2021-2026) & (k units) Table 64. Europe OPO-containing Infant Formulas Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific OPO-containing Infant Formulas Sales by Application (2021-2026) & (k units) Table 66. Asia-Pacific OPO-containing Infant Formulas Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America OPO-containing Infant Formulas Sales by Application (2021-2026) & (k units) Table 68. Latin America OPO-containing Infant Formulas Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa OPO-containing Infant Formulas Sales by Application (2021-2026) & (k units) Table 70. Middle East and Africa OPO-containing Infant Formulas Sales by Application (2021-2026) & (US$ Million) Table 71. BiosTime Company Information Table 72. BiosTime Business Overview Table 73. BiosTime OPO-containing Infant Formulas Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 74. BiosTime OPO-containing Infant Formulas Product Portfolio Table 75. BiosTime Recent Development Table 76. Nutriben Company Information Table 77. Nutriben Business Overview Table 78. Nutriben OPO-containing Infant Formulas Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 79. Nutriben OPO-containing Infant Formulas Product Portfolio Table 80. Nutriben Recent Development Table 81. Ausnutria Company Information Table 82. Ausnutria Business Overview Table 83. Ausnutria OPO-containing Infant Formulas Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 84. Ausnutria OPO-containing Infant Formulas Product Portfolio Table 85. Ausnutria Recent Development Table 86. HERDS Company Information Table 87. HERDS Business Overview Table 88. HERDS OPO-containing Infant Formulas Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 89. HERDS OPO-containing Infant Formulas Product Portfolio Table 90. HERDS Recent Development Table 91. Milupa Company Information Table 92. Milupa Business Overview Table 93. Milupa OPO-containing Infant Formulas Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 94. Milupa OPO-containing Infant Formulas Product Portfolio Table 95. Milupa Recent Development Table 96. Shanxi Yatai Company Information Table 97. Shanxi Yatai Business Overview Table 98. Shanxi Yatai OPO-containing Infant Formulas Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 99. Shanxi Yatai OPO-containing Infant Formulas Product Portfolio Table 100. Shanxi Yatai Recent Development Table 101. Beingmate Company Information Table 102. Beingmate Business Overview Table 103. Beingmate OPO-containing Infant Formulas Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 104. Beingmate OPO-containing Infant Formulas Product Portfolio Table 105. Beingmate Recent Development Table 106. Abbott Company Information Table 107. Abbott Business Overview Table 108. Abbott OPO-containing Infant Formulas Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 109. Abbott OPO-containing Infant Formulas Product Portfolio Table 110. Abbott Recent Development Table 111. Brightdairy Company Information Table 112. Brightdairy Business Overview Table 113. Brightdairy OPO-containing Infant Formulas Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 114. Brightdairy OPO-containing Infant Formulas Product Portfolio Table 115. Brightdairy Recent Development Table 116. Feihe Company Information Table 117. Feihe Business Overview Table 118. Feihe OPO-containing Infant Formulas Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 119. Feihe OPO-containing Infant Formulas Product Portfolio Table 120. Feihe Recent Development Table 121. Wyeth Nutrition Company Information Table 122. Wyeth Nutrition Business Overview Table 123. Wyeth Nutrition OPO-containing Infant Formulas Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 124. Wyeth Nutrition OPO-containing Infant Formulas Product Portfolio Table 125. Wyeth Nutrition Recent Development Table 126. Deloraine Company Information Table 127. Deloraine Business Overview Table 128. Deloraine OPO-containing Infant Formulas Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 129. Deloraine OPO-containing Infant Formulas Product Portfolio Table 130. Deloraine Recent Development Table 131. Yili Company Information Table 132. Yili Business Overview Table 133. Yili OPO-containing Infant Formulas Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 134. Yili OPO-containing Infant Formulas Product Portfolio Table 135. Yili Recent Development Table 136. Kabrita Company Information Table 137. Kabrita Business Overview Table 138. Kabrita OPO-containing Infant Formulas Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 139. Kabrita OPO-containing Infant Formulas Product Portfolio Table 140. Kabrita Recent Development Table 141. North America OPO-containing Infant Formulas Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 142. North America OPO-containing Infant Formulas Sales by Country (2021-2026) & (k units) Table 143. North America OPO-containing Infant Formulas Sales Market Share by Country (2021-2026) Table 144. North America OPO-containing Infant Formulas Sales Forecast by Country (2027-2032) & (k units) Table 145. North America OPO-containing Infant Formulas Sales Market Share Forecast by Country (2027-2032) Table 146. North America OPO-containing Infant Formulas Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 147. North America OPO-containing Infant Formulas Market Size by Country (2021-2026) & (US$ Million) Table 148. North America OPO-containing Infant Formulas Market Share by Country (2021-2026) Table 149. North America OPO-containing Infant Formulas Market Size Forecast by Country (2027-2032) & (US$ Million) Table 150. North America OPO-containing Infant Formulas Market Share Forecast by Country (2027-2032) Table 151. Europe OPO-containing Infant Formulas Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 152. Europe OPO-containing Infant Formulas Sales by Country (2021-2026) & (k units) Table 153. Europe OPO-containing Infant Formulas Sales Market Share by Country (2021-2026) Table 154. Europe OPO-containing Infant Formulas Sales Forecast by Country (2027-2032) & (k units) Table 155. Europe OPO-containing Infant Formulas Sales Market Share Forecast by Country (2027-2032) Table 156. Europe OPO-containing Infant Formulas Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 157. Europe OPO-containing Infant Formulas Market Size by Country (2021-2026) & (US$ Million) Table 158. Europe OPO-containing Infant Formulas Market Share by Country (2021-2026) Table 159. Europe OPO-containing Infant Formulas Market Size Forecast by Country (2027-2032) & (US$ Million) Table 160. Europe OPO-containing Infant Formulas Market Share Forecast by Country (2027-2032) Table 161. Asia-Pacific OPO-containing Infant Formulas Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 162. Asia-Pacific OPO-containing Infant Formulas Sales by Country (2021-2026) & (k units) Table 163. Asia-Pacific OPO-containing Infant Formulas Sales Market Share by Country (2021-2026) Table 164. Asia-Pacific OPO-containing Infant Formulas Sales Forecast by Country (2027-2032) & (k units) Table 165. Asia-Pacific OPO-containing Infant Formulas Sales Market Share Forecast by Country (2027-2032) Table 166. Asia-Pacific OPO-containing Infant Formulas Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 167. Asia-Pacific OPO-containing Infant Formulas Market Size by Country (2021-2026) & (US$ Million) Table 168. Asia-Pacific OPO-containing Infant Formulas Market Share by Country (2021-2026) Table 169. Asia-Pacific OPO-containing Infant Formulas Market Size Forecast by Country (2027-2032) & (US$ Million) Table 170. Asia-Pacific OPO-containing Infant Formulas Market Share Forecast by Country (2027-2032) Table 171. Latin America OPO-containing Infant Formulas Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 172. Latin America OPO-containing Infant Formulas Sales by Country (2021-2026) & (k units) Table 173. Latin America OPO-containing Infant Formulas Sales Market Share by Country (2021-2026) Table 174. Latin America OPO-containing Infant Formulas Sales Forecast by Country (2027-2032) & (k units) Table 175. Latin America OPO-containing Infant Formulas Sales Market Share Forecast by Country (2027-2032) Table 176. Latin America OPO-containing Infant Formulas Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 177. Latin America OPO-containing Infant Formulas Market Size by Country (2021-2026) & (US$ Million) Table 178. Latin America OPO-containing Infant Formulas Market Share by Country (2021-2026) Table 179. Latin America OPO-containing Infant Formulas Market Size Forecast by Country (2027-2032) & (US$ Million) Table 180. Latin America OPO-containing Infant Formulas Market Share Forecast by Country (2027-2032) Table 181. Middle East and Africa OPO-containing Infant Formulas Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 182. Middle East and Africa OPO-containing Infant Formulas Sales by Country (2021-2026) & (k units) Table 183. Middle East and Africa OPO-containing Infant Formulas Sales Market Share by Country (2021-2026) Table 184. Middle East and Africa OPO-containing Infant Formulas Sales Forecast by Country (2027-2032) & (k units) Table 185. Middle East and Africa OPO-containing Infant Formulas Sales Market Share Forecast by Country (2027-2032) Table 186. Middle East and Africa OPO-containing Infant Formulas Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 187. Middle East and Africa OPO-containing Infant Formulas Market Size by Country (2021-2026) & (US$ Million) Table 188. Middle East and Africa OPO-containing Infant Formulas Market Share by Country (2021-2026) Table 189. Middle East and Africa OPO-containing Infant Formulas Market Size Forecast by Country (2027-2032) & (US$ Million) Table 190. Middle East and Africa OPO-containing Infant Formulas Market Share Forecast by Country (2027-2032) Table 191. Key Raw Materials Table 192. Raw Materials Key Suppliers Table 193. OPO-containing Infant Formulas Distributors List Table 194. OPO-containing Infant Formulas Customers List Table 195. Research Programs/Design for This Report Table 196. Authors List of This Report Table 197. Secondary Sources Table 198. Primary Sources List of Figures Figure 1. OPO-containing Infant Formulas Image Figure 2. Global OPO-containing Infant Formulas Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global OPO-containing Infant Formulas Market Size (2021-2032) & (US$ Million) Figure 4. Global OPO-containing Infant Formulas Sales (2021-2032) & (k units) Figure 5. Cow Milk Formula Image Figure 6. Global Cow Milk Formula Sales YoY Growth (2021-2032) & (k units) Figure 7. Goat Milk Formula Image Figure 8. Global Goat Milk Formula Sales YoY Growth (2021-2032) & (k units) Figure 9. Global OPO-containing Infant Formulas Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global OPO-containing Infant Formulas Market Share by Type 2025 VS 2032 Figure 11. North America OPO-containing Infant Formulas Sales Market Share in Volume by Type in 2025 Figure 12. North America OPO-containing Infant Formulas Sales Market Share in Value by Type in 2025 Figure 13. Europe OPO-containing Infant Formulas Sales Market Share in Volume by Type in 2025 Figure 14. Europe OPO-containing Infant Formulas Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific OPO-containing Infant Formulas Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific OPO-containing Infant Formulas Sales Market Share in Value by Type in 2025 Figure 17. Latin America OPO-containing Infant Formulas Sales Market Share in Volume by Type in 2025 Figure 18. Latin America OPO-containing Infant Formulas Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa OPO-containing Infant Formulas Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa OPO-containing Infant Formulas Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 OPO-containing Infant Formulas Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. 0 - 6 Month Image Figure 24. Global 0 - 6 Month Sales YoY Growth (2021-2032) & (k units) Figure 25. 6 - 12 Month Image Figure 26. Global 6 - 12 Month Sales YoY Growth (2021-2032) & (k units) Figure 27. 12 - 36 Month Image Figure 28. Global 12 - 36 Month Sales YoY Growth (2021-2032) & (k units) Figure 29. Global OPO-containing Infant Formulas Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global OPO-containing Infant Formulas Market Share by Application 2025 VS 2032 Figure 31. North America OPO-containing Infant Formulas Sales Market Share in Volume by Application in 2025 Figure 32. North America OPO-containing Infant Formulas Sales Market Share in Value by Application in 2025 Figure 33. Europe OPO-containing Infant Formulas Sales Market Share in Volume by Application in 2025 Figure 34. Europe OPO-containing Infant Formulas Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific OPO-containing Infant Formulas Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific OPO-containing Infant Formulas Sales Market Share in Value by Application in 2025 Figure 37. Latin America OPO-containing Infant Formulas Sales Market Share in Volume by Application in 2025 Figure 38. Latin America OPO-containing Infant Formulas Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa OPO-containing Infant Formulas Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa OPO-containing Infant Formulas Sales Market Share in Value by Application in 2025 Figure 41. North America OPO-containing Infant Formulas Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 42. North America OPO-containing Infant Formulas Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America OPO-containing Infant Formulas Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America OPO-containing Infant Formulas Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe OPO-containing Infant Formulas Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 46. Europe OPO-containing Infant Formulas Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe OPO-containing Infant Formulas Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe OPO-containing Infant Formulas Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific OPO-containing Infant Formulas Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 50. Asia-Pacific OPO-containing Infant Formulas Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific OPO-containing Infant Formulas Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific OPO-containing Infant Formulas Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America OPO-containing Infant Formulas Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 54. Latin America OPO-containing Infant Formulas Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America OPO-containing Infant Formulas Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America OPO-containing Infant Formulas Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa OPO-containing Infant Formulas Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 58. Middle East and Africa OPO-containing Infant Formulas Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa OPO-containing Infant Formulas Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa OPO-containing Infant Formulas Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. OPO-containing Infant Formulas Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. OPO-containing Infant Formulas Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • Cow Milk Formula
  • Goat Milk Formula
Applications
  • 0 - 6 Month
  • 6 - 12 Month
  • 12 - 36 Month
Companies covered
  • BiosTime
  • Nutriben
  • Ausnutria
  • HERDS
  • Milupa
  • Shanxi Yatai
  • Beingmate
  • Abbott
  • Brightdairy
  • Feihe
  • Wyeth Nutrition
  • Deloraine
  • Yili
  • Kabrita

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global OPO-containing Infant Formulas Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global OPO-containing Infant Formulas Sales Estimates and Forecasts (2021-2032)
  5. 1.3 OPO-containing Infant Formulas Market by Type
  6. 1.3.1 Cow Milk Formula
  7. 1.3.2 Goat Milk Formula
  8. 1.4 Global OPO-containing Infant Formulas Market Size by Type
  9. 1.4.1 Global OPO-containing Infant Formulas Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global OPO-containing Infant Formulas Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global OPO-containing Infant Formulas Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America OPO-containing Infant Formulas Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe OPO-containing Infant Formulas Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific OPO-containing Infant Formulas Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America OPO-containing Infant Formulas Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa OPO-containing Infant Formulas Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 OPO-containing Infant Formulas Industry Trends
  2. 2.2 OPO-containing Infant Formulas Industry Drivers
  3. 2.3 OPO-containing Infant Formulas Industry Opportunities and Challenges
  4. 2.4 OPO-containing Infant Formulas Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by OPO-containing Infant Formulas Revenue (2021-2026)
  2. 3.2 Global Top Players by OPO-containing Infant Formulas Sales (2021-2026)
  3. 3.3 Global Top Players by OPO-containing Infant Formulas Price (2021-2026)
  4. 3.4 Global OPO-containing Infant Formulas Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global OPO-containing Infant Formulas Major Company Production Sites & Headquarters
  6. 3.6 Global OPO-containing Infant Formulas Company, Product Type & Application
  7. 3.7 Global OPO-containing Infant Formulas Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global OPO-containing Infant Formulas Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 OPO-containing Infant Formulas Players Market Share by Revenue in 2025
  11. 3.8.3 2025 OPO-containing Infant Formulas Tier 1, Tier 2, and Tier 3
4 OPO-containing Infant Formulas Regional Status and Outlook
  1. 4.1 Global OPO-containing Infant Formulas Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global OPO-containing Infant Formulas Historic Market Size by Region
  3. 4.2.1 Global OPO-containing Infant Formulas Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global OPO-containing Infant Formulas Sales in Value by Region (2021-2026)
  5. 4.2.3 Global OPO-containing Infant Formulas Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global OPO-containing Infant Formulas Forecasted Market Size by Region
  7. 4.3.1 Global OPO-containing Infant Formulas Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global OPO-containing Infant Formulas Sales in Value by Region (2027-2032)
  9. 4.3.3 Global OPO-containing Infant Formulas Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 OPO-containing Infant Formulas by Application
  1. 5.1 OPO-containing Infant Formulas Market by Application
  2. 5.1.1 0 - 6 Month
  3. 5.1.2 6 - 12 Month
  4. 5.1.3 12 - 36 Month
  5. 5.2 Global OPO-containing Infant Formulas Market Size by Application
  6. 5.2.1 Global OPO-containing Infant Formulas Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global OPO-containing Infant Formulas Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global OPO-containing Infant Formulas Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America OPO-containing Infant Formulas Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe OPO-containing Infant Formulas Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific OPO-containing Infant Formulas Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America OPO-containing Infant Formulas Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa OPO-containing Infant Formulas Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 BiosTime
  2. 6.1.1 BiosTime Company Information
  3. 6.1.2 BiosTime Business Overview
  4. 6.1.3 BiosTime OPO-containing Infant Formulas Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 BiosTime OPO-containing Infant Formulas Product Portfolio
  6. 6.1.5 BiosTime Recent Developments
  7. 6.2 Nutriben
  8. 6.2.1 Nutriben Company Information
  9. 6.2.2 Nutriben Business Overview
  10. 6.2.3 Nutriben OPO-containing Infant Formulas Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Nutriben OPO-containing Infant Formulas Product Portfolio
  12. 6.2.5 Nutriben Recent Developments
  13. 6.3 Ausnutria
  14. 6.3.1 Ausnutria Company Information
  15. 6.3.2 Ausnutria Business Overview
  16. 6.3.3 Ausnutria OPO-containing Infant Formulas Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Ausnutria OPO-containing Infant Formulas Product Portfolio
  18. 6.3.5 Ausnutria Recent Developments
  19. 6.4 HERDS
  20. 6.4.1 HERDS Company Information
  21. 6.4.2 HERDS Business Overview
  22. 6.4.3 HERDS OPO-containing Infant Formulas Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 HERDS OPO-containing Infant Formulas Product Portfolio
  24. 6.4.5 HERDS Recent Developments
  25. 6.5 Milupa
  26. 6.5.1 Milupa Company Information
  27. 6.5.2 Milupa Business Overview
  28. 6.5.3 Milupa OPO-containing Infant Formulas Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Milupa OPO-containing Infant Formulas Product Portfolio
  30. 6.5.5 Milupa Recent Developments
  31. 6.6 Shanxi Yatai
  32. 6.6.1 Shanxi Yatai Company Information
  33. 6.6.2 Shanxi Yatai Business Overview
  34. 6.6.3 Shanxi Yatai OPO-containing Infant Formulas Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Shanxi Yatai OPO-containing Infant Formulas Product Portfolio
  36. 6.6.5 Shanxi Yatai Recent Developments
  37. 6.7 Beingmate
  38. 6.7.1 Beingmate Company Information
  39. 6.7.2 Beingmate Business Overview
  40. 6.7.3 Beingmate OPO-containing Infant Formulas Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Beingmate OPO-containing Infant Formulas Product Portfolio
  42. 6.7.5 Beingmate Recent Developments
  43. 6.8 Abbott
  44. 6.8.1 Abbott Company Information
  45. 6.8.2 Abbott Business Overview
  46. 6.8.3 Abbott OPO-containing Infant Formulas Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Abbott OPO-containing Infant Formulas Product Portfolio
  48. 6.8.5 Abbott Recent Developments
  49. 6.9 Brightdairy
  50. 6.9.1 Brightdairy Company Information
  51. 6.9.2 Brightdairy Business Overview
  52. 6.9.3 Brightdairy OPO-containing Infant Formulas Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Brightdairy OPO-containing Infant Formulas Product Portfolio
  54. 6.9.5 Brightdairy Recent Developments
  55. 6.10 Feihe
  56. 6.10.1 Feihe Company Information
  57. 6.10.2 Feihe Business Overview
  58. 6.10.3 Feihe OPO-containing Infant Formulas Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Feihe OPO-containing Infant Formulas Product Portfolio
  60. 6.10.5 Feihe Recent Developments
  61. 6.11 Wyeth Nutrition
  62. 6.11.1 Wyeth Nutrition Company Information
  63. 6.11.2 Wyeth Nutrition Business Overview
  64. 6.11.3 Wyeth Nutrition OPO-containing Infant Formulas Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Wyeth Nutrition OPO-containing Infant Formulas Product Portfolio
  66. 6.11.5 Wyeth Nutrition Recent Developments
  67. 6.12 Deloraine
  68. 6.12.1 Deloraine Company Information
  69. 6.12.2 Deloraine Business Overview
  70. 6.12.3 Deloraine OPO-containing Infant Formulas Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Deloraine OPO-containing Infant Formulas Product Portfolio
  72. 6.12.5 Deloraine Recent Developments
  73. 6.13 Yili
  74. 6.13.1 Yili Company Information
  75. 6.13.2 Yili Business Overview
  76. 6.13.3 Yili OPO-containing Infant Formulas Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Yili OPO-containing Infant Formulas Product Portfolio
  78. 6.13.5 Yili Recent Developments
  79. 6.14 Kabrita
  80. 6.14.1 Kabrita Company Information
  81. 6.14.2 Kabrita Business Overview
  82. 6.14.3 Kabrita OPO-containing Infant Formulas Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 Kabrita OPO-containing Infant Formulas Product Portfolio
  84. 6.14.5 Kabrita Recent Developments
7 North America by Country
  1. 7.1 North America OPO-containing Infant Formulas Sales by Country
  2. 7.1.1 North America OPO-containing Infant Formulas Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America OPO-containing Infant Formulas Sales by Country (2021-2026)
  4. 7.1.3 North America OPO-containing Infant Formulas Sales Forecast by Country (2027-2032)
  5. 7.2 North America OPO-containing Infant Formulas Market Size by Country
  6. 7.2.1 North America OPO-containing Infant Formulas Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America OPO-containing Infant Formulas Market Size by Country (2021-2026)
  8. 7.2.3 North America OPO-containing Infant Formulas Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe OPO-containing Infant Formulas Sales by Country
  2. 8.1.1 Europe OPO-containing Infant Formulas Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe OPO-containing Infant Formulas Sales by Country (2021-2026)
  4. 8.1.3 Europe OPO-containing Infant Formulas Sales Forecast by Country (2027-2032)
  5. 8.2 Europe OPO-containing Infant Formulas Market Size by Country
  6. 8.2.1 Europe OPO-containing Infant Formulas Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe OPO-containing Infant Formulas Market Size by Country (2021-2026)
  8. 8.2.3 Europe OPO-containing Infant Formulas Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific OPO-containing Infant Formulas Sales by Country
  2. 9.1.1 Asia-Pacific OPO-containing Infant Formulas Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific OPO-containing Infant Formulas Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific OPO-containing Infant Formulas Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific OPO-containing Infant Formulas Market Size by Country
  6. 9.2.1 Asia-Pacific OPO-containing Infant Formulas Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific OPO-containing Infant Formulas Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific OPO-containing Infant Formulas Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America OPO-containing Infant Formulas Sales by Country
  2. 10.1.1 South America OPO-containing Infant Formulas Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America OPO-containing Infant Formulas Sales by Country (2021-2026)
  4. 10.1.3 South America OPO-containing Infant Formulas Sales Forecast by Country (2027-2032)
  5. 10.2 South America OPO-containing Infant Formulas Market Size by Country
  6. 10.2.1 South America OPO-containing Infant Formulas Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America OPO-containing Infant Formulas Market Size by Country (2021-2026)
  8. 10.2.3 South America OPO-containing Infant Formulas Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa OPO-containing Infant Formulas Sales by Country
  2. 11.1.1 Middle East and Africa OPO-containing Infant Formulas Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa OPO-containing Infant Formulas Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa OPO-containing Infant Formulas Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa OPO-containing Infant Formulas Market Size by Country
  6. 11.2.1 Middle East and Africa OPO-containing Infant Formulas Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa OPO-containing Infant Formulas Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa OPO-containing Infant Formulas Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 OPO-containing Infant Formulas Value Chain Analysis
  2. 12.1.1 OPO-containing Infant Formulas Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 OPO-containing Infant Formulas Production Mode & Process
  7. 12.2 OPO-containing Infant Formulas Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 OPO-containing Infant Formulas Distributors
  10. 12.2.3 OPO-containing Infant Formulas Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst